24/7 Patient Assistance: 760-405-8205

Gregory M. Lubiniecki, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information

    Dr. Gregory Lubiniecki got his medical degree from Johns Hopkins University and residency at Mayo School of Graduate Medical Education. After a few years he went to University of Pennsylvania Health System and completed his fellowship in hematology/oncology. Dr. Lubiniecki is board certified in medical oncology and hematology. He has between 11 and 20 years of practice and is affiliated with Fox Chase Cancer Center.


    Insurance Accepted

    AetnaCignaHumanaMultiPlan


  • Education & Training

    dept_icon

    Johns Hopkins University

    Medical School

    dept_icon

    Mayo School of Graduate Medical Education

    Residency

    dept_icon

    University of Pennsylvania Health System

    Fellowship

  • Board Certifications

    American Board of Internal Medicine - Hematology

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Fox Chase Cancer Center

    Languages: English/Spanish

    (215) 728-6900

    7701 Burholme Ave

    Philadelphia, Pennsylvania 19111

    Read More
  • Publications & Memberships

    Dr. Gregory M. Lubiniecki has contributed to 3 publications.

    Thromboembolic events with estramustine phosphate-based chemotherapy in patients with hormone-refractory prostate carcinoma: results of a meta-analysis.

    Lubiniecki, G.M., Berlin, J.A., Weinstein, R.B., Vaughn, D.J.; Cancer. 2004 Dec 15.

    See more >>

    Her-2/neu expression in ovarian cancer: pre- and postexposure to platinum chemotherapy

    Peethambaram, P. P., Cliby, W. A., Lubiniecki, G., Clayton, A. C., Roche, P. C., Iturria, S. J., Hartmann, L. C., Hellström, I., Strome, S. E.; Gynecol Oncol. 2003 Apr.

    See more >>

    A phase I and pharmacologic study of DMP 840 administered by 24-hour infusion.

    O'Reilly, S., Baker, S. D., Sartorius, S., Rowinsky, E. K., Finizio, M., Lubiniecki, G. M., Grochow, L. B., Gray, J. E., Pieniaszek, H. J., Donehower, R. C.; Ann Oncol. 1998 Jan.

    See more >>

    Memberships

    American College of Physicians

    American Medical Association

    American Society of Clinical Oncology

    American Society of Hematology

    International Association for the Study of Lung Cancer

    Pennsylvania Medical Society